CHSE Biotechnology and Its Applications
CHSE Biotechnology and Its Applications
CHSE Biotechnology and Its Applications
➢ Soil bacterium Pseudomonas syringae contains a gene that promotes ice nucleation. Using
gene technology, this gene is deleted and a mutant P. syringae is engineered known as INA or
ice-minus strain which prevents frost (ice) formation when sprayed on crops.
Bioplastic:
➢ An alternative to natural plastic called bioplastic, has been developed using biotechnology.
➢ Certain group of microorganisms synthesize biopolymers similar to natural plastic.
➢ The gene encoding the enzyme for biopolymer synthesis is isolated and transferred to corn
plant cells in culture and transgenic corn plants generated, which express the transgene and
synthesize the biodegradable polymer which is used as bioplastic. It does not cause
environmental pollution.
Novel Transgenic Plants:
➢ In Petunia, a gene that codes enzymes for flower colour was introduced in protoplasts and a
trans genic plant with pink flowers was generated.
➢ Florigene, a biotech company in 1996 released the first ever genetically manipulated flower
into the market
➢ Another example of the novel plant is the luminescent tobacco plant which is generated
through gene manipulation.
➢ The luciferase gene of bacteria or firefly expresses luciferase enzyme. It acts on the substrate
luciferin and turns it into a product, which glows in dark. This phenomenon is known as
bioluminescence.
➢ The tobacco plant cells in culture are transformed by a recombinant Ti plasmid containing a
luciferase gene. Plants, generated, glow in dark in the presence of the substrate luciferin.
Protein Producing Plants:
➢ Transgenic plants also serve as bioreactors for the synthesis of many therapeutic mammalian
proteins such as enkephalin (a neuro-peptide) and human serum albumin.
Golden Rice:
➢ It is a genetically modified rice that contain increased level of β-carotene (a precursor of
vitamin-A) which is produced by introducing genes encoding the enzymes of β-carotene
biosynthetic pathway into rice plant cells in culture.
➢ It is light yellow in colour and helps to prevent night-blindness in the world.
Delayed Fruit Ripening (Flavr Savr Tomato):
➢ Usually, tomato is a food item which is consumed everywhere in the world. It is a seasonal
vegetable and persists for a short duration due to its fast ripening and rotting.
➢ The ripening of tomato occurs due to the synthesis of polygalacturonase enzyme which
degrades the pectin of tomato.
➢ By the application of biotechnology, the polygalacturonase enzyme was blocked so that the
ripening and rotting of tomato is delayed.
➢ These genetically engineered tomatoes are known as Flavr-Savr tomato.
Nitrogen-Fixation:
➢ The atmospheric nitrogen is trapped by soil microorganisms and converted into soluble nitrate
by a process, called biological nitrogen fixation. This process is catalysed by an enzyme
complex, nitrogenase, encoded by nitrogen fixing (nif) genes.
➢ The nif gene can be transferred from the genome of Rhizobium into the chromosomes of non-
2
Bt Cotton:
➢ Some strains of bacterium Bacillus thuringiensis have proteins that kill insects like coleopterans
(beetles), lepidopterans (tobacco budworm, army worm) & dipterans (flies, mosquitoes).
➢ B. thuringiensis forms a toxic insecticidal protein (Bt toxin) crystal during a particular phase of
their growth. These crystals do not kill the Bacillus as it exists as inactive protoxins.
➢ When an insect ingests the inactive toxin, it is converted into active toxin due to the alkaline
pH of the gut which solubilise the crystals. The active toxin binds to the surface of mid gut
epithelial cells and creates pores. It causes cell swelling, lysis and finally death of the insect.
➢ These Bt toxin genes were isolated from B. thuringiensis and incorporated into crop plants such
as cotton.
➢ Most Bt toxins are insect-group specific. This toxin is coded by a gene called cry.
➢ E.g.,
✓ The proteins encoded by the genes cry IAc and cry IIAb control the cotton bollworms
✓ cry IAb control corn borer.
✓ cry IIIAb controls Colorado potato beetle
✓ cry IIIBb controls corn rot worm.
➢ These two RNAs are complementary to each other and formed a double stranded (dsRNA)
that initiated RNAi and thus, silenced the specific mRNA of nematode.
➢ Thus, the parasite cannot survive in a transgenic host expressing specific interfering RNA.
APPLICATIONS IN MEDICINE
➢ The recombinant DNA technology helps for the mass production of safe and more effective
therapeutic drugs.
➢ The recombinant therapeutics does not induce unwanted immunological responses as is
common in case of similar products isolated from non-human sources.
➢ At present, about 30 recombinant therapeutics have been approved for human-use. In India,
12 of these are presently being marketed.
Recombinant Vaccine:
➢ The vaccines produced through genetic engineering methods are called recombinant vaccines
or second-generation vaccines.
➢ They have gene inserts for the surface proteins of a pathogen that bring out immunity but do
not result in infection
➢ These plasmids are inserted in bacteria or yeast cells that express the viral proteins which are
then injected into human host as vaccine.
➢ E.g., Hepatitis-B vaccine, Polio vaccine
4
Page
Stem Cell:
➢ These are undifferentiated biological cells that can differentiate into specialized cells and can
divide through mitosis to produce more stem cells.
➢ These are mainly of 2 types. i.e., embryonic stem cell (isolated from inner cell mass of
blastocyst) and adult stem cell (exist throughout the body after embryonic development
including brain).
➢ The potential applications of stem cell include organ and tissue regeneration, bone marrow
transplantation, brain disease treatment, blood disease treatment etc.
Gene Therapy
➢ It is a method to correct a gene defect (hereditary disease) diagnosed in a child or embryo.
➢ It can be achieved by the following methods.
i. By replacement of a defective gene with a normal gene.
ii. By correcting a defective gene through gene targeting.
iii. By gene augmentation, i.e., normal foreign gene sequences are introduced for defective
gene.
➢ First clinical gene therapy was attempted in 1990 on a 4-year-old girl with adenosine
deaminase (ADA) deficiency by M Blease and WF Andresco of National Institute of Health.
➢ The disorder is caused due to the deletion of the gene for adenosine deaminase (the enzyme
crucial for the immune system to function).
➢ This can be cured by bone marrow transplantation or by enzyme replacement therapy
(injection of functional ADA). But these approaches are not completely curative.
➢ This is why gene therapy was introduced.
➢ Steps in enzyme replacement gene therapy:
✓ Lymphocytes from the patient’s blood are grown in a culture outside the body.
✓ A functional adenosine deaminase cDNA (using a retroviral vector) is introduced into
these lymphocytes.
✓ Then, they are returned to the patient. This should be periodically repeated as these cells
are not immortal. However, if the ADA gene (from marrow cells) is introduced into cells
at early embryonic stages, it could be a permanent cure.
➢ Some other diseases that can be treated by gene therapy are haemophilia, cystic fibrosis etc.
Molecular Diagnosis:
➢ Recombinant DNA technology, PCR (Polymerase Chain Reaction) and Enzyme Linked
Immuno-Sorbent Assay (ELISA) are some techniques for early diagnosis.
5
Page
➢ The term ‘transgenic’ was first given by Gorden and Ruddle in 1983.
➢ These are the animals whose genome has been altered by introduction of an extra (foreign)
gene by manipulation.
➢ The process by which these animals are formed is called transgenesis.
➢ E.g., Transgenic rats, rabbits, pigs, sheep, cows and fish.
➢ Over 95% of all existing transgenic animals are mice (supermouse).
➢ In 1996, cloning was revolutionized when Ian Wilmut and his colleagues at the Roslin-
Institute in Edinburgh, Scotland, successfully cloned a sheep named Dolly. Dolly was the first
cloned mammal.
✓ This gives information about the biological role of the factor in the body.
Page
Note: Bio-safety- Biosafety is defined as, “The discipline addressing the safe handling and
containment of infectious microorganisms and hazardous biological materials”. In India,
Department of biotechnology is the nodal centre for Indian biosafety network.
ETHICAL ISSUES
1. Problem of unpredictable results:
➢ Genetic modification may cause unpredictable results when such organisms are introduced
into the ecosystem.
➢ Therefore, there is a need for some ethical standards to evaluate our actions. These set of
standards that are used to regulate activities in relation to biological world are called bioethics.
➢ In order to control these issues, Indian Government has set up organizations like GEAC
(Genetic Engineering Approval Committee), which make decisions about the validity of GM
research and the safety of GM-organisms for public services.
2. Problems of Patent:
Patent:
➢ It is a set of exclusive rights granted by a government to an inventor or their assignee for a
limited period of time to prevent others from commercial use of their invention.
➢ Patents are supposed to satisfy three criteria of: Novelty, Non-obviousness, and Utility.
➢ Novelty implies that the innovation must be new. It cannot be part of ‘prior art’ or existing
knowledge.
7
Page
➢ Non-obviousness implies that it may not be documented but is otherwise well known.
➢ The discorded fact or product should be of a particular use for the human beings.
➢ When the patent is granted for biological entities and for products derived from them, they are
called bio-patents.
➢ Primarily, USA, Japan and members of European Union are awarding bio-patents.
3. Biopiracy:
➢ It is the use of bio-resources by multinational companies and other organizations without
proper authorization from the countries and people concerned (also without compensatory
payment).
➢ Most of the industrialized nations are financially rich but poor in biodiversity and traditional
knowledge.
➢ The developing and the underdeveloped world have rich biodiversity and traditional
knowledge related to bio-resources. Hence, these countries have to develop laws to prevent
8
Animal cloning and making of Dolly: Ian Wilmut of Roslin Institute of Scotland came up with a
cloned sheep, named Dolly in February, 1997. He used nuclear transplantation technique to create
Dolly, a clone of sheep. This was the first ever clone of an animal. Following this, two other sheep,
named, Polly and Molly were also created in the same manner.
9
Page